ライフサイエンスコーパス: Propionibacterium

1 cus, Finegoldia, Micrococcus, Prevotella and Propionibacterium).

2 ptures skin commensal microbiota, especially Propionibacterium.

3 scherichia coli (3), Candida tropicalis (1), Propionibacterium (1), and Rothia (1).

4 Mobiluncus (8), Peptostreptococcus (16), and Propionibacterium (24).

5 (10) CFU/g), Bifidobacterium (1 x 10(10)/g), Propionibacterium (3 x 10(10)/g), Acetobacter (1 x 10(6)

6 acteria Staphylococcus, Corynebacterium, and Propionibacterium (6.5, 5.7, 5.4 log10 copies/100 mL, re

7 10.5%), Olsenella (9.4%), Prevotella (8.8%), Propionibacterium (7.2%), Streptococcus (3.9%), Selenomo

8 investigated the acid tolerance mechanism of Propionibacterium acidipropionici at microenvironmental

9 46% vs 80%; 3) the most frequent isolate was Propionibacterium acnes (11/26) vs coagulase-negative St

10 1), Propionibacterium species (n = 15), and Propionibacterium acnes (n = 19) isolates; all of these

11 S (20 microg/mouse) 7 days after heat-killed Propionibacterium acnes (P. acnes) injection into wild-t

12 monstrate that fermentation of glycerol with Propionibacterium acnes (P. acnes), a skin commensal bac

13 ne treatment as a natural antibiotic against Propionibacterium acnes (P. acnes), which promotes folli

14 e investigated the roles of TLR2 and TLR4 in Propionibacterium acnes (P. acnes)-primed, LPS-induced l

15 nd cDC2s during bacterial infection, notably Propionibacterium acnes (P. acnes).

16 nas and Peptoniphilus species (type IV), and Propionibacterium acnes (type V).

17 In this issue, Kistowska et al. confirm that Propionibacterium acnes activates inflammasomes leading

18 asts, 6 nonfermenters, and 1 isolate each of Propionibacterium acnes and coagulase-negative staphyloc

19 Propionibacterium acnes and coagulase-negative Staphyloc

20 olleagues present strain-based resolution of Propionibacterium acnes and its association with the com

21 the presence of the Gram-positive bacterium Propionibacterium acnes and its potential association wi

22 In vivo Th1 response to Propionibacterium acnes and lipopolysaccharide in IFN-ga

23 nished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.

24 s associated with formation of resistance in Propionibacterium acnes and other bacteria, with clinica

25 ndependent growth, requiring helpers such as Propionibacterium acnes and Prevotella intermedia for st

26 on in common skin commensal bacteria such as Propionibacterium acnes and Staphylococcus epidermitis.

27 Low virulence organisms such as Propionibacterium acnes are the most common culprit orga

28 We report a patient with Propionibacterium acnes bacteremia and late prosthetic v

29 ites from the abundant skin-resident microbe Propionibacterium acnes can influence cytokine expressio

30 n are compounded by increasing resistance of Propionibacterium acnes clinical isolates.

31 resulting from the immune response targeting Propionibacterium acnes has a significant role in its pa

32 Propionibacterium acnes has been identified as a signifi

33 The microaerophylic organism Propionibacterium acnes has shown consistent association

34 ase-negative staphylococci in 6.0% (27/448), Propionibacterium acnes in 4.7% (21/448), and Pseudomona

35 Agak et al. report that Propionibacterium acnes induces IL-17 expression in peri

36 Propionibacterium acnes induction of IL-1 cytokines thro

37 Propionibacterium acnes induction of inflammatory respon

38 have been sensitized to endotoxin damage by Propionibacterium acnes infection.

39 Propionibacterium acnes is a critical component in the p

40 Propionibacterium acnes is a key pathogen involved in th

41 Propionibacterium acnes is a key therapeutic target in a

42 Propionibacterium acnes is a known cause of postneurosur

43 Propionibacterium acnes is a major etiological factor of

44 The Gram-positive bacterium Propionibacterium acnes is a member of the normal human

45 Propionibacterium acnes is a skin commensal bacterium th

46 Propionibacterium acnes is a well-known cause of delayed

47 Propionibacterium acnes is also associated with inflamma

48 The opportunistic human pathogen Propionibacterium acnes is composed of a number of disti

49 Propionibacterium acnes is increasingly recognized as an

50 Propionibacterium acnes isolates usually have relatively

51 stigated the in vitro susceptibilities of 23 Propionibacterium acnes ophthalmic isolates to ertapenem

52 Mycothiol production was not detected in Propionibacterium acnes or in representative species of

53 relative abundances of propionibacteria and Propionibacterium acnes phage in healthy skin.

54 overed, including Escherichia coli phage T3, Propionibacterium acnes phage PA6, and Streptococcus mit

55 on of early childhood acne, the emergence of Propionibacterium acnes resistance, and the rare but ser

56 observed the decline of an early-colonizing Propionibacterium acnes strain similar to SK137 and the

57 ny countries reporting that more than 50% of Propionibacterium acnes strains are resistant to topical

58 es of the human skin microbiome suggest that Propionibacterium acnes strains may contribute different

59 Prevotella oris, Staphylococcus aureus, and Propionibacterium acnes strains.

60 ddress the emergence of antibiotic-resistant Propionibacterium acnes strains.

61 s-wide comparative analysis of 90 genomes of Propionibacterium acnes that represent the known diversi

62 nflammation is due in part to the ability of Propionibacterium acnes to activate TLR2.

63 C57BL/6 mice treated with Propionibacterium acnes to elicit high levels of macroph

64 ntial evidence that links the skin bacterium Propionibacterium acnes to the condition.

65 The culture supernatant of a strain of Propionibacterium acnes was investigated for its phospho

66 Propionibacterium acnes was the commonest species detect

67 cular hyperkeratinization, and the action of Propionibacterium acnes within the follicle.

68 Cutibacterium acnes (formerly Propionibacterium acnes) is recognized as a pathogen in

69 iome at the strain level and genome level of Propionibacterium acnes, a dominant skin commensal, betw

70 mechanism by which S. aureus may commandeer Propionibacterium acnes, a key member of the human skin

71 Propionibacterium acnes, causative agent of chronic pros

72 Bradyrhizobium, Anaerococcus, Peptoniphilus, Propionibacterium acnes, Dorea, and Ruminococcus and red

73 rial pathogens including Bacillus anthracis, Propionibacterium acnes, Enterococcus faecalis, and both

74 Among the airborne microorganisms, Propionibacterium acnes, Escherichia coli, Acinetobacter

75 e primed 12 days in advance with heat-killed Propionibacterium acnes, IL-18BP-Fc prevents LPS-induced

76 In patients with AgP, Actinomyces oris, Propionibacterium acnes, P. aeruginosa, Staphylococcus a

77 teen of the species or phylotypes, including Propionibacterium acnes, Staphylococcus spp., and the op

78 rect antimicrobial activity in vitro against Propionibacterium acnes, the bacterium linked to the pat

79 ct to sequence multiple clinical isolates of Propionibacterium acnes, we have produced a draft genome

80 teria such as Staphylococcus epidermidis and Propionibacterium acnes, were identified in bacteriologi

81 ulture showed antimicrobial activity against Propionibacterium acnes, whereas the enhanced antimicrob

82 ica charantia Linn. var. abbreviata Ser.) on Propionibacterium acnes-induced inflammation and to iden

83 us studies showed that TLR9 and TLR2 mediate Propionibacterium acnes-induced sensitization to lipopol

84 ion of 2.0 micrograms per milliliter against Propionibacterium acnes.

85 against Escherichia coli., and 12 mm against Propionibacterium acnes.

86 licles on the face, neck, chest, and back by Propionibacterium acnes.

87 e immune response to the commensal bacterium Propionibacterium acnes.

88 antimicrobial activity against S. aureus and Propionibacterium acnes.

89 es, is caused by multiple factors, including Propionibacterium acnes.

90 t contributes to the pathogenesis of acne is Propionibacterium acnes; yet, the molecular mechanism by

91 and four different Cutibacterium (previously Propionibacterium) acnes strains, and compare outcomes w

92 ilar to SK137 and the proliferation of novel Propionibacterium and Peptoniphilus species late in colo

93 Increases in Streptococcus, Propionibacterium, and Corynebacterium species were obse

94 e of the genera Enterococcus, Lactobacillus, Propionibacterium, and Streptococcus and two clones were

95 r proportions of Shinella, Terribacillus and Propionibacterium, and these genera are known to have to

96 cus, Finegoldia, Micrococcus, Prevotella and Propionibacterium at all time points, suggesting their p

97 loss of skin commensals (Corynebacterium and Propionibacterium) at the surgical site, which were repl

98 loss of skin commensals (Corynebacterium and Propionibacterium) at the surgical site, which were repl

99 Regardless, 12 genera-Pseudomonas, Propionibacterium, Bradyrhizobium, Corynebacterium, Acin

100 rder Corynebacterineae; revisions within the Propionibacterium, Clostridium, Borrelia, and Enterobact

101 well as bacterial genus-specific probes for Propionibacterium, Corynebacterium, Streptococcus, and S

102 with aeroallergen sensitization compared to Propionibacterium dominance (OR: 4.48, FDR = 0.03).

103 Propionibacterium FMA5 was significantly associated with

104 identity to PP(i)-PFKs from two eubacteria, Propionibacterium freudenreichii and Sinorhizobium melil

105 Co-expression of the cobA gene from Propionibacterium freudenreichii and the cbiA, -C, -D, -

106 The well-studied PPi-PFK of Propionibacterium freudenreichii is highly divergent and

107 acillus casei, Levilactobacillus brevis, and Propionibacterium freudenreichii resulted in the product

108 human active vitamin B12 in cell extracts of Propionibacterium freudenreichii subsp. shermanii and af

109 through solid-state fermentation (SSF) using Propionibacterium freudenreichii.

110 We have tentatively named this new species Propionibacterium humerusii.

111 dobacterium animalis subsp. lactis BB-12 and Propionibacterium jensenii 702.

112 s developed as a useful tool for engineering Propionibacterium jensenii, and two key enzymes-glycerol

113 healthy controls vs HS skin, indicating that Propionibacterium may be part of the pathogenesis in HS.

114 reported that the newly discovered commensal Propionibacterium, P.

115 gibacterium, Peptostreptococcus, Prevotella, Propionibacterium, Selenomonas, Solobacterium, Streptoco

116 Both activities purified from Propionibacterium shermanii are the functional propertie

117 tetradehydrocorrin, factor IV, isolated from Propionibacterium shermanii has been established by mult

118 Transcarboxylase from Propionibacterium shermanii is a 1.2 MDa multienzyme com

119 million Dalton (Da) multienzyme complex from Propionibacterium shermanii that couples two carboxylati

120 A 75-residue sequence from Propionibacterium shermanii that is biotinylated in mamm

121 in-accepting domain from the 1.3S subunit of Propionibacterium shermanii transcarboxylase (PSBT) is t

122 hift by fusing a compact protein domain, the Propionibacterium shermanii transcarboxylase domain (PST

123 Transcarboxylase (TC) from Propionibacterium shermanii, a biotin-dependent enzyme,

124 .7.1.90) which was purified from extracts of Propionibacterium shermanii.

125 by the action of the biosynthetic enzymes of Propionibacterium shermanii.

126 Several taxa, including Propionibacterium, showed a significantly higher relativ

127 The isolation of Propionibacterium sp. from broth only usually represente

128 To detect anaerobic Propionibacterium sp., a well-described cause of these i

129 cluded Bacteroides thetaiotaomicron (n = 1), Propionibacterium species (n = 15), and Propionibacteriu

130 The Propionibacterium species differed in their ability to m

131 uded multiple Actinomyces species in wounds, Propionibacterium species in joints and cerebrospinal fl

132 produced a draft genome sequence of a novel Propionibacterium species that is closely related to, ye

133 ative Staphylococcus, Candida, Fusarium, and Propionibacterium species).

134 phaga species, six Actinomyces species, four Propionibacterium species, and eight Streptococcus speci

135 Propionibacterium species, coagulase-negative staphyloco

136 e gut microbiota, particularly enrichment of Propionibacterium species.

137 9 (51%) of these bottles grew Cutibacterium (Propionibacterium) species.

138 ertinent to former designations of or within Propionibacterium spp., Corynebacterium spp., Clostridiu

139 m infants or a newly identified and cultured Propionibacterium strain, P.

140 ptostreptococcus, Porphyromonas, Provetella, Propionibacterium, Tisierella, and Veillonella and 36 of

141 media/Prevotella nigrescens, Capnocytophaga, Propionibacterium, yeasts, Actinobacillus actinomycetemc